Tumour-suppressive microRNA-224 inhibits cancer cell migration and invasion via targeting oncogenic TPD52 in prostate cancer.
about
Prognostic Impact of miR-224 and RAS Mutations in Medullary Thyroid Carcinoma.Decreased microRNA-224 and its clinical significance in non-small cell lung cancer patientsMicroRNA expression signature of oral squamous cell carcinoma: functional role of microRNA-26a/b in the modulation of novel cancer pathways.Expression and role of oncogenic miRNA-224 in esophageal squamous cell carcinoma.MicroRNA-224 promotes tumor progression in nonsmall cell lung cancerMicroRNA-224 is implicated in lung cancer pathogenesis through targeting caspase-3 and caspase-7Epigenetic silencing of miR-145-5p contributes to brain metastasisGlobal proteomic profiling in multistep hepatocarcinogenesis and identification of PARP1 as a novel molecular marker in hepatocellular carcinoma.MicroRNA-224 inhibits proliferation and migration of breast cancer cells by down-regulating Fizzled 5 expression.Dual-strand tumor-suppressor microRNA-145 (miR-145-5p and miR-145-3p) coordinately targeted MTDH in lung squamous cell carcinoma.Functional significance of aberrantly expressed microRNAs in prostate cancer.MicroRNA-224: as a potential target for miR-based therapy of cancer.Regulation of metastasis-promoting LOXL2 gene expression by antitumor microRNAs in prostate cancer.Direct regulation of LAMP1 by tumor-suppressive microRNA-320a in prostate cancer.Regulation of E3 ubiquitin ligase-1 (WWP1) by microRNA-452 inhibits cancer cell migration and invasion in prostate cancer.Tumor-suppressive microRNA-223 inhibits cancer cell migration and invasion by targeting ITGA3/ITGB1 signaling in prostate cancer.MicroRNA expression signature of castration-resistant prostate cancer: the microRNA-221/222 cluster functions as a tumour suppressor and disease progression marker.Deciphering the function of non-coding RNAs in prostate cancer.MicroRNA-205 inhibits cancer cell migration and invasion via modulation of centromere protein F regulating pathways in prostate cancer.Aberrantly expressed microRNAs in bladder cancer and renal cell carcinoma.Pontin, a new mutant p53-binding protein, promotes gain-of-function of mutant p53.Tumour-suppressive microRNA-24-1 inhibits cancer cell proliferation through targeting FOXM1 in bladder cancer.Regulation of TPD52 by antitumor microRNA-218 suppresses cancer cell migration and invasion in lung squamous cell carcinoma.Tumor-suppressive microRNA-34a inhibits breast cancer cell migration and invasion via targeting oncogenic TPD52.Tumour-suppressive microRNA-144-5p directly targets CCNE1/2 as potential prognostic markers in bladder cancer.Predictive relevance of miR-34a, miR-224 and miR-342 in patients with advanced squamous cell carcinoma of the lung undergoing palliative chemotherapy.MiRNAs at the Crossroads between Innate Immunity and Cancer: Focus on Macrophages.LncRNA-TUSC7/miR-224 affected chemotherapy resistance of esophageal squamous cell carcinoma by competitively regulating DESC1.miR-224 enhances invasion and metastasis by targeting HOXD10 in non-small cell lung cancer cells.Androgen-dependent alternative mRNA isoform expression in prostate cancer cellsLong non‑coding RNA ferritin heavy polypeptide 1 pseudogene 3 controls glioma cell proliferation and apoptosis via regulation of the microRNA‑224‑5p/tumor protein D52 axis
P2860
Q33813776-6141DC9E-024B-4F10-8DBB-7E88F3D381CAQ34578852-1B726370-A31C-4D6D-BD4E-B0FA6715132AQ35678702-2BB8FF0D-FB1D-4608-9454-4443F14EFAB3Q35738190-0AEA8DDF-2194-4658-A9A4-66FD05517745Q35946366-651CA1B7-E558-47EC-B183-77EA8D4A2E7FQ36355801-1D125794-5453-4755-92DC-315325FC12D1Q36546293-E71F48B1-AE1B-4F2D-9674-A47B4153425DQ37046449-6B78CAC5-5AB0-414C-BF66-AD6B146AE322Q37580183-49CDD837-278D-48D2-BE92-8396FD69EF4AQ37687781-9E3BAAA8-C0C9-4D72-8B53-6EF9C08685BDQ38323461-67B08C5A-1732-40E5-94DB-26B80CC3D326Q38562796-4602F1E4-06E2-47EC-9E10-3CFE8978F911Q38765720-B7F4F17E-2C2C-4900-ACFA-416EACA8145DQ38769219-078D8797-7962-4E81-86E7-CA9BB8737C46Q38778872-DD1E0010-A72A-43E6-AA58-B7E430F0FE2EQ38824206-2067AC37-A702-4759-8E76-424A6C195909Q38839158-CE195FBF-BE7E-41E7-8B3C-30223CC78242Q38843392-BB2CFC14-0702-4552-8435-C436760625A9Q38865588-A16C4A59-5083-43DF-B4D4-E5AB026EEC77Q38881055-C2F10A7A-EC0B-43D9-A922-653775BA864AQ38889305-4C38EA24-371C-45BB-AF2F-2B7675371A62Q38977601-119645CA-40E6-4BF1-892C-578E44F29E8FQ39384713-D68F19AA-FEDC-4A1C-85AA-770CD4D330B4Q40200300-0A5D4290-9CD5-44AD-A27F-56314A9D4E89Q41684266-E4E8ECDA-4509-4E90-A4BB-7F4608B81BB3Q49277521-759F7263-3846-42E7-8F5A-2D1331A3FAE8Q50117508-B2015574-6296-4FD6-B9A3-8A8F65A283F1Q52660177-1079FDA6-2942-43A8-B590-2F9656C3CFADQ55380508-4133CFD1-4416-4B88-8511-6B9F314D4ED6Q57135534-BC4EED01-4747-496F-81D6-C3796755E1C0Q57157341-F0793D9D-AE2C-499F-BB63-5247A796664C
P2860
Tumour-suppressive microRNA-224 inhibits cancer cell migration and invasion via targeting oncogenic TPD52 in prostate cancer.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Tumour-suppressive microRNA-22 ...... enic TPD52 in prostate cancer.
@en
Tumour-suppressive microRNA-22 ...... enic TPD52 in prostate cancer.
@nl
type
label
Tumour-suppressive microRNA-22 ...... enic TPD52 in prostate cancer.
@en
Tumour-suppressive microRNA-22 ...... enic TPD52 in prostate cancer.
@nl
prefLabel
Tumour-suppressive microRNA-22 ...... enic TPD52 in prostate cancer.
@en
Tumour-suppressive microRNA-22 ...... enic TPD52 in prostate cancer.
@nl
P2093
P2860
P1433
P1476
Tumour-suppressive microRNA-22 ...... enic TPD52 in prostate cancer.
@en
P2093
Hideki Enokida
Masayuki Nakagawa
Naohiko Seki
Rika Nishikawa
Satoko Kojima
Satoru Inoguchi
Shinichi Sakamoto
Takashi Kinoshita
Takeshi Chiyomaru
P2860
P304
P356
10.1016/J.FEBSLET.2014.04.020
P407
P577
2014-04-24T00:00:00Z